Advertisement

The Rheumatic Diseases: A Primer

  • Bella Mehta
  • C. Ronald MacKenzieEmail author
  • Stephen Paget
Chapter
  • 26 Downloads

Abstract

The rheumatic diseases are an important category of chronic illness. Affecting many millions of Americans, these conditions are a leading cause of disability and contribute significantly to premature mortality in those afflicted. Given their prevalence, the rheumatic diseases contribute disproportionately to the population of patients who will require orthopedic surgery. This chapter presents a broad overview of these conditions and their underlying pathophysiology, diagnosis, and treatment.

Keywords

Osteoarthritis Connective tissue disease Spondyloarthropathies Synovium Rheumatologist 

References

  1. 1.
    Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part I. Arthritis Rheum. 2008;58:15–25.CrossRefGoogle Scholar
  2. 2.
    Abramson S, Attur M. Developments in the scientific understanding of osteoarthritis. Arthritis Res Ther. 2009;11:227–35.CrossRefGoogle Scholar
  3. 3.
    Li B, Aspden RM. Mechanical and material properties of the subchondral bone plate from the femoral head of patients with osteoarthritis or osteoporosis. Ann Rheum Dis. 1997;56:247–54.CrossRefGoogle Scholar
  4. 4.
    Goldring SR, Goldring MB. Clinical aspects, pathology and pathophysiology of osteoarthritis. J Musculoskelet Neuronal Interact. 2006;6:376–8.PubMedGoogle Scholar
  5. 5.
    MacKenzie CR, Paget SA. Perioperative care of the rheumatic disease patient. In: Hochberg MC, Silman AJ, Smolen MS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Mosby Elsevier; 2010.Google Scholar
  6. 6.
    MacKenzie CR, Sharrock NE. Perioperative medical considerations in patients with rheumatoid arthritis. Rheum Dis Clin North Am. 1998;24:1–17.CrossRefGoogle Scholar
  7. 7.
    Brandt KD. Defining osteoarthritis: what it is, and what it is not. J Musculoskelet Med. 2010;27:1–12.Google Scholar
  8. 8.
    Sims KJ, Richardson CA, Brauer SG. Investigation of hip abductor activation in subjects with clinical unilateral hip osteoarthritis. Ann Rheum Dis. 2002;61:687–92.CrossRefGoogle Scholar
  9. 9.
    Becker R, Berth A, Nehring M, Awiszus F. Neuromuscular quadriceps dysfunction prior to osteoarthritis of the knee. J Orthop Res. 2004;22(4):768–73.CrossRefGoogle Scholar
  10. 10.
    Gaston JS. Cellular immunity in rheumatoid arthritis. In: Hochberb M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Mosby; 2011. p. 897–934.CrossRefGoogle Scholar
  11. 11.
    Hochberb M, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, editors. Rheumatology. 5th ed. Philadelphia: Mosby; 2001. p. 897–934.Google Scholar
  12. 12.
    Goldring SR, Gravallese EM. Pathogenesis of bone erosions in rheumatoid arthritis. Curr Opin Rheumatol. 2000;12:195–9.CrossRefGoogle Scholar
  13. 13.
    Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 1987;30:1205–13.CrossRefGoogle Scholar
  14. 14.
    Goodyear CS, Tighe H, McInnes IB. Chapter 51: Rheumatoid factors and other autoantibodies in rheumatoid arthritis. In: Firestein GS, Budd RC, Harris Jr ED, et al., editors. Kelley’s textbook of rheumatology. 8th ed. Philadelphia: W.B. Saunders Company; 2008.Google Scholar
  15. 15.
    Whiting PF, Smidt N, Sterne JA, Harbord R, Burton A, Burke M, et al. Systematic review: accuracy of anti-citrullinated peptide antibodies for diagnosis rheumatoid arthritis. Ann Intern Med. 2010;152(7):456.CrossRefGoogle Scholar
  16. 16.
    Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakazawa T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797.CrossRefGoogle Scholar
  17. 17.
    Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet. 2009;373:659–72.CrossRefGoogle Scholar
  18. 18.
    Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, et al. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 2008;67:212–7.CrossRefGoogle Scholar
  19. 19.
    Van der Helm-van Mil AH, Padyukov L, Toes RE, Klareskog L, Huizinga TW. Genome-wide single-nucleotide polymorphism studies in rheumatology: hype or hope? Arthritis Rheum. 2008;58(9):2591–7.Google Scholar
  20. 20.
    Van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, de Jong BA, Breedveld FC, Verweij CL, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum. 2004;50:709–15.CrossRefGoogle Scholar
  21. 21.
    Fessel WJ. Systemic lupus erythematosus in the community: incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974;134:1027–35.CrossRefGoogle Scholar
  22. 22.
    Lahita RG. Special report: adjusted lupus prevalence: results of a marketing study by the Lupus Foundation of America. Lupus. 1995;4:450–3.CrossRefGoogle Scholar
  23. 23.
    Powell C, Chang C, Gershwin ME. Current concepts on the pathogenesis and natural history of steroid-induced osteonecrosis. Clin Rev Allergy Immunol. 2010;41:102–13.CrossRefGoogle Scholar
  24. 24.
    Steen VD, Medsger TA. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437–44.CrossRefGoogle Scholar
  25. 25.
    Bogoch ER, Gross DK. Surgery of the hand in patients with systemic sclerosis: outcomes and considerations. J Rheumatol. 2005;32:642–8.PubMedGoogle Scholar
  26. 26.
    Rudwaleit M, van der Heijde D, Landewe R, Akkoc N, Brandt J, Chou CT, et al. The Assessment of SpondloArthritis International Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25–31.CrossRefGoogle Scholar
  27. 27.
    Moll JMH, Wright V. New York clinical criteria for ankylosing spondylitis; a statistical evaluation. Ann Rheum Dis. 1973;32:354–63.Google Scholar
  28. 28.
    Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.CrossRefGoogle Scholar
  29. 29.
    Amor B, Dougados M, Mijiyawa M. Criteres de classification des spondylarthropathies. Rev Rhum. 1990;57:85–9.PubMedGoogle Scholar
  30. 30.
    Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. European Spondyloarthropathy Study Group (ESSG): preliminary criteria for the classification of spondyloarthropathy. Arthritis Rheum. 1991;34:1218–27.CrossRefGoogle Scholar
  31. 31.
    Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009;68(6):777–83.CrossRefGoogle Scholar
  32. 32.
    Mease P. Management of psoriatic arthritis: the therapeutic interface between rheumatology and dermatology. Curr Rheumatol Rep. 2006;8(5):348–54.CrossRefGoogle Scholar
  33. 33.
    Griffith JF, Engelke K, Genant HK. Looking beyond bone mineral density. Ann N Y Acad Sci. 2010;1192:45–56.CrossRefGoogle Scholar
  34. 34.
    Arromdee E, Michet CJ, Crowson CS, O’Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol. 2002;29(11):2403–6.PubMedGoogle Scholar
  35. 35.
    Johansen IS, Nielsen SL, Hove M, Kehrer M, Shakar S, Wøyen AV, et al. Characteristics and clinical outcome of bone and joint tuberculosis from 1994 to 2011: a retrospective register-based study in Denmark. Clin Infect Dis. 2015;61(4):554–62.CrossRefGoogle Scholar
  36. 36.
    West SG, Kotzin BL. Sarcoidosis. In: Hochberg MC, et al., editors. Rheumatology. 3rd ed. Edinburgh: Mosby Elsevier; 2003. p. 1735–52.Google Scholar
  37. 37.
    Strand V, Kimberly R, Isaacs JD. Biologic therapies in rheumatology: lessons learned, future directions. Nat Rev Drug Discov. 2007;6:75–92.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Bella Mehta
    • 1
    • 2
  • C. Ronald MacKenzie
    • 3
    Email author
  • Stephen Paget
    • 4
  1. 1.Department of RheumatologyHospital for Special SurgeryNew YorkUSA
  2. 2.Department of MedicineWeill Cornell MedicineNew YorkUSA
  3. 3.Departments of Rheumatology and Medicine the Hospital for Special Surgery Weill Cornell MedicineNew YorkUSA
  4. 4.Department of RheumatologyWeill Cornell/Hospital for Special Surgery/New York PresbyterianNew YorkUSA

Personalised recommendations